Valparin: Clinical Profile and Therapeutic Applications in Neurological Disorders

Overview and Clinical Context Valparin is a pharmaceutical formulation of valproic acid, specifically designed as a delayed-release or enteric-coated preparation to minimize gastrointestinal side effects while maintaining therapeutic efficacy. It belongs to the class of broad-spectrum antiepileptic drugs and mood stabilizers, with a mechanism of action that extends beyond simple sodium channel blockade. The drug has been in clinical use since the 1970s, but its modern formulations—particularly the enteric-coated and extended-release versions—represent significant improvements over the original immediate-release preparations.